GLENN LEVINE to Humans
This is a "connection" page, showing publications GLENN LEVINE has written about Humans.
Connection Strength
0.867
-
Erectile Dysfunction and Coronary Artery?Disease: Unfortunate Bedfellows. J Am Coll Cardiol. 2024 01 23; 83(3):427-429.
Score: 0.024
-
Association of pessimism with cardiovascular events and all-cause mortality. Prog Cardiovasc Dis. 2023 Jan-Feb; 76:91-98.
Score: 0.023
-
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022 10 11; 146(15):e205-e223.
Score: 0.022
-
Psychological Stress and Heart Disease: Fact or Folklore? Am J Med. 2022 06; 135(6):688-696.
Score: 0.021
-
Association of Optimism with Cardiovascular Events and All-Cause Mortality: Systematic Review and Meta-Analysis. Am J Med. 2022 07; 135(7):856-863.e2.
Score: 0.021
-
Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association. Circulation. 2021 03 09; 143(10):e763-e783.
Score: 0.020
-
Toward a More Detailed Reporting of MI Reduction in Clinical Trials-A Welcome and Needed Step in the Right Direction. JAMA Cardiol. 2020 07 01; 5(7):793-794.
Score: 0.019
-
Meditation and Cardiovascular Health in the US. Am J Cardiol. 2020 09 15; 131:23-26.
Score: 0.019
-
ISCHEMIA-CKD: Contemporary Randomized Clinical Data at Last. Circulation. 2020 08 11; 142(6):520-522.
Score: 0.019
-
Expanding Traditional Cardiac Rehabilitation in the 21st Century. J Am Coll Cardiol. 2020 04 07; 75(13):1562-1564.
Score: 0.019
-
Pet Ownership and Cardiovascular Health in the US General Population. Am J Cardiol. 2020 04 15; 125(8):1158-1161.
Score: 0.019
-
Writing a Trustworthy Hypertension Guideline. J Am Coll Cardiol. 2019 11 12; 74(19):2424-2427.
Score: 0.018
-
The Mind-Heart-Body Connection. Circulation. 2019 10 22; 140(17):1363-1365.
Score: 0.018
-
Recent Innovations, Modifications,?and?Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our?Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical?Practice?Guidelines. J Am Coll Cardiol. 2019 Apr 23; 73(15):1990-1998.
Score: 0.017
-
In-Hospital ST-Segment Elevation Myocardial Infarction: Improving Diagnosis, Triage, and Treatment. JAMA Cardiol. 2018 06 01; 3(6):527-531.
Score: 0.016
-
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2017 Sep 28; 6(10).
Score: 0.016
-
Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet Therapy. JAMA. 2017 07 11; 318(2):194-195.
Score: 0.016
-
It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy Debates. Circulation. 2017 06 20; 135(25):2451-2453.
Score: 0.015
-
Adding CABG to the Dual Antiplatelet?Salad. J Am Coll Cardiol. 2017 01 17; 69(2):128-130.
Score: 0.015
-
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016 11; 152(5):1243-1275.
Score: 0.015
-
PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary?Artery?Disease. J Am Coll Cardiol. 2016 09 06; 68(10):1066-81.
Score: 0.015
-
Editorial commentary: The continuing evolution of primary PCI and clinical guidelines. Trends Cardiovasc Med. 2017 02; 27(2):103-105.
Score: 0.014
-
Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction. JAMA Cardiol. 2016 05 01; 1(2):226-7.
Score: 0.014
-
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation. 2016 Sep 06; 134(10):e123-55.
Score: 0.014
-
2016 ACC/AHA Guideline Focused?Update on Duration of Dual?Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2016 09 06; 68(10):1082-115.
Score: 0.014
-
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016 Mar 15; 133(11):1135-47.
Score: 0.014
-
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol. 2016 Mar 15; 67(10):1235-1250.
Score: 0.014
-
Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014 Oct; 11(10):597-606.
Score: 0.013
-
World heart federation expert consensus statement on antiplatelet therapy in east asian patients with ACS or undergoing PCI. Glob Heart. 2014 Dec; 9(4):457-67.
Score: 0.013
-
Sexual activity and ischemic heart disease. Curr Cardiol Rep. 2014 Feb; 16(2):445.
Score: 0.012
-
Pet ownership and cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2013 Jun 11; 127(23):2353-63.
Score: 0.012
-
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2012 Feb 15; 79(3):453-95.
Score: 0.011
-
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012 Feb 28; 125(8):1058-72.
Score: 0.011
-
2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E266-355.
Score: 0.010
-
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011 Dec 06; 58(24):e44-122.
Score: 0.010
-
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin. 2010 May-Jun; 60(3):194-201.
Score: 0.009
-
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation. 2010 Feb 16; 121(6):833-40.
Score: 0.009
-
Weighing the benefits and risks of magnetic resonance scanning of patients with implanted cardiovascular devices. Pol Arch Med Wewn. 2008 Jan-Feb; 118(1-2):8-9.
Score: 0.008
-
Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007 Dec 11; 116(24):2878-91.
Score: 0.008
-
Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals. Pharmacotherapy. 2006 Nov; 26(11):1537-56.
Score: 0.007
-
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade. Catheter Cardiovasc Interv. 2005 Oct; 66(2):149-57.
Score: 0.007
-
Optimizing Psychological Health Across the Perinatal Period: An Update on Maternal Cardiovascular Health: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2025 Mar 04; 14(5):e041369.
Score: 0.007
-
Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. J Thromb Thrombolysis. 2004 Jun; 17(3):167-71.
Score: 0.006
-
Low-molecular-weight heparin during percutaneous coronary interventions: rationale, results, and recommendations. Catheter Cardiovasc Interv. 2003 Oct; 60(2):185-93.
Score: 0.006
-
Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med. 2003 Jul 15; 139(2):123-36.
Score: 0.006
-
Decongestion Models and Metrics in Acute Heart Failure: ESCAPE Data in the Age of the Implantable Cardiac Pressure Monitor. Tex Heart Inst J. 2022 07 01; 49(4).
Score: 0.005
-
The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes. Panminerva Med. 2002 Jun; 44(2):115-22.
Score: 0.005
-
Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention. Am J Cardiol. 2022 07 01; 174:182-184.
Score: 0.005
-
A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents? Curr Cardiol Rep. 2022 06; 24(6):689-698.
Score: 0.005
-
Is There an Optimal Antiplatelet Strategy after Gastrointestinal Bleeding in Patients with Coronary Artery Disease? Cardiology. 2021; 146(6):668-677.
Score: 0.005
-
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. Circulation. 2021 06 22; 143(25):e1035-e1087.
Score: 0.005
-
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. J Am Coll Cardiol. 2021 06 22; 77(24):3079-3133.
Score: 0.005
-
2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2021 Aug; 162(2):e183-e353.
Score: 0.005
-
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2021 Jul; 162(1):e23-e106.
Score: 0.005
-
Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review. JAMA. 2021 Apr 20; 325(15):1545-1555.
Score: 0.005
-
Antithrombotic therapy in patients with acute coronary syndromes. Arch Intern Med. 2001 Apr 09; 161(7):937-48.
Score: 0.005
-
Reduction of thrombus burden with eptifibatide in a patient with a non-ST segment elevation acute coronary syndrome. J Invasive Cardiol. 2000 Dec; 12 Suppl D:21D-2D.
Score: 0.005
-
Mortality differences among patients with in-hospital ST-elevation myocardial infarction. Clin Cardiol. 2020 Dec; 43(12):1555-1561.
Score: 0.005
-
Racial and Geographic Disparities in Internet Use in the United States Among Patients with Atherosclerotic Cardiovascular Disease. Am J Cardiol. 2020 11 01; 134:146-147.
Score: 0.005
-
Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines? Cardiovasc Drugs Ther. 2020 12; 34(6):865-870.
Score: 0.005
-
US Rural Surgeon Responses to the COVID-19 Pandemic: Leadership in a Time of Crisis. Am Surg. 2020 Jun; 86(6):602-610.
Score: 0.005
-
Improving adherence to cardiovascular guidelines: realistic transition from paper to patient. Expert Rev Cardiovasc Ther. 2020 Jan; 18(1):41-51.
Score: 0.005
-
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease. Can J Cardiol. 2020 08; 36(8):1298-1307.
Score: 0.005
-
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ. 2019 Oct 10; 367:l5476.
Score: 0.005
-
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon. Cardiovasc Drugs Ther. 2019 10; 33(5):589-597.
Score: 0.005
-
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
Score: 0.004
-
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther. 2019 05; 24(3):215-224.
Score: 0.004
-
ACC/AHA Versus ESC Guidelines on Dual?Antiplatelet Therapy: JACC Guideline Comparison. J Am Coll Cardiol. 2018 12 11; 72(23 Pt A):2915-2931.
Score: 0.004
-
The CHA2DS2-VASc score: Not as simple as it seems. Int J Cardiol. 2018 04 15; 257:92-96.
Score: 0.004
-
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018 01 14; 39(3):213-260.
Score: 0.004
-
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2018 01 01; 53(1):34-78.
Score: 0.004
-
The role of percutaneous revascularization in the treatment of ischemic heart disease: insights from published reports and randomized clinical trials. Chest. 1997 Sep; 112(3):805-21.
Score: 0.004
-
Use of bare-mounted Palmaz-Schatz stents employing the stent saddle technique on the delivery balloon: a single center experience. Cathet Cardiovasc Diagn. 1997 Aug; 41(4):361-8.
Score: 0.004
-
2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vasc Med. 2017 06; 22(3):NP1-NP43.
Score: 0.004
-
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. Am J Cardiol. 1997 Mar 15; 79(6):748-55.
Score: 0.004
-
2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2016 May; 87(6):1001-19.
Score: 0.004
-
Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1996 Mar 15; 93(6):1107-13.
Score: 0.004
-
Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016 Feb 16; 133(7):680-6.
Score: 0.003
-
Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 04 05; 67(13):1572-1574.
Score: 0.003
-
Exercise training and blood viscosity in patients with ischemic heart disease. Am J Cardiol. 1995 Jul 01; 76(1):80-1.
Score: 0.003
-
Acute, reversible left ventricular dysfunction in status asthmaticus. Chest. 1995 May; 107(5):1469-73.
Score: 0.003
-
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):e5-23.
Score: 0.003
-
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23; 130(25):e344-426.
Score: 0.003
-
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23; 130(25):2354-94.
Score: 0.003
-
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23; 64(24):e139-e228.
Score: 0.003
-
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014 Nov 04; 130(19):1749-67.
Score: 0.003
-
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014 Nov 04; 64(18):1929-49.
Score: 0.003
-
Early experience of a transcatheter aortic valve program at a Veterans Affairs facility. JAMA Surg. 2013 Dec; 148(12):1087-93.
Score: 0.003
-
ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures: a Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). Catheter Cardiovasc Interv. 2013 Aug 01; 82(2):E69-111.
Score: 0.003
-
ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing committee to revise the 2007 clinical competence statement on cardiac interventional procedures). Circulation. 2013 Jul 23; 128(4):436-72.
Score: 0.003
-
ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). J Am Coll Cardiol. 2013 Jul 23; 62(4):357-96.
Score: 0.003
-
Transcatheter aortic valve replacement as a treatment for late apicoaortic conduit obstruction in a patient with severe aortic stenosis. Circulation. 2013 Mar 19; 127(11):e491-4.
Score: 0.003
-
Establishment of a transcatheter aortic valve program and heart valve team at a Veterans Affairs facility. Am J Surg. 2012 Nov; 204(5):643-8.
Score: 0.003
-
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2012 Jul; 144(1):39-71.
Score: 0.003
-
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventions American Association for Thoracic Surgery American Heart Association, American Society of Echocardiography American Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society, Society of Critical Care Medicine Society of Cardiovascular Computed Tomography Society for Cardiovascular Magnetic Resonance Society of Thoracic Surgeons. Catheter Cardiovasc Interv. 2012 Sep 01; 80(3):E50-81.
Score: 0.003
-
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 01; 75(6):928-35.
Score: 0.002
-
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. Int J Cardiol. 2010 Sep 24; 144(1):36-41.
Score: 0.002
-
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Int J Cardiol. 2010 Mar 04; 139(2):123-33.
Score: 0.002
-
Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III. J Invasive Cardiol. 2007 Dec; 19(12):525-38; quiz 539-40.
Score: 0.002
-
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 2007 Nov 06; 50(19):1914-31.
Score: 0.002
-
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2007 Dec; 28(24):3076-93.
Score: 0.002
-
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007 Nov 06; 116(19):2216-33.
Score: 0.002
-
Universal definition of myocardial infarction. Circulation. 2007 Nov 27; 116(22):2634-53.
Score: 0.002
-
Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report. J Invasive Cardiol. 2006 Dec; 18(12):617-39.
Score: 0.002
-
Malignant pleural/pericardial effusion with tamponade and life-threatening reversible myocardial depression in a case of an initial presentation of lung adenocarcinoma. Cardiology. 2006; 105(1):30-3.
Score: 0.002
-
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9.
Score: 0.001
-
Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS. J Invasive Cardiol. 2003 Sep; 15(9):536-53.
Score: 0.001
-
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial. J Am Coll Cardiol. 2003 Feb 05; 41(3):386-93.
Score: 0.001
-
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels. Thromb Res. 2003; 112(5-6):301-6.
Score: 0.001
-
In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. Am J Cardiol. 2002 Jan 01; 89(1):61-4.
Score: 0.001